CTOs on the Move

Commonwealth Diagnostics International

www.commdx.com

 
Commonwealth Diagnostics International (CDI), Inc., was founded on the principle that preventative healthcare, including early detection and diagnosis of disease, results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Operating out of a newly constructed laboratory in Salem, MA, CDI is an international diagnostic service provider specializing in innovative diagnostic products that assist physicians and patients with the diagnosis and management of some of the world`s most common sources of digestive distress and functional gastrointestinal disorders, including: hydrogen (H2)/methane (CH4) breath testing for Small Intestinal Bacterial Overgrowth (SIBO) and carbohydrate malabsorption, IBSchek™ for ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.commdx.com
  • 39 Norman Street
    Salem, MA USA 01970
  • Phone: 888.258.5966

Executives

Name Title Contact Details
Nathaniel Allen
Director of Information Technology Profile

Similar Companies

HCA West Florida

HCA West Florida is a Largo, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CRF Health

With operation centers in the United States and the United Kingdom and an R&D center of excellence in Finland, CRF Health is committed to driving the global change to higher-quality outcomes and more efficient paper-free clinical trials through improved patient engagement via intuitive and patient-focused eCOA (electronic Clinical Outcome Assessment) technology. By improving the process of conducting clinical studies, we help companies bring new medicines to market quickly, safely and more cost-effectively.

Dietz Hwkins Internal Medicine

Dietz Hwkins Internal Medicine is a Sandy, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New Line Medical Inc

New Line Medical Inc is a Breaux Bridge, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Halberd Corporation

Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.